BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32306475)

  • 41. Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises.
    Izraeli S
    Curr Opin Hematol; 2014 Jul; 21(4):289-96. PubMed ID: 24848770
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Jain S; Abraham A
    Arch Pathol Lab Med; 2020 Feb; 144(2):150-155. PubMed ID: 31644323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia.
    Yao QM; Liu KY; Gale RP; Jiang B; Liu YR; Jiang Q; Jiang H; Zhang XH; Zhang MJ; Chen SS; Huang XJ; Xu LP; Ruan GR
    BMC Cancer; 2016 Apr; 16():269. PubMed ID: 27067989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
    Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variant of ETV6/ABL1 gene is associated with leukemia phenotype.
    Park J; Kim M; Lim J; Kim Y; Han K; Kim JS; Lee S; Kim HJ; Min WS
    Acta Haematol; 2013; 129(2):78-82. PubMed ID: 23171811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
    Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like-Recent Progress in Treatment.
    Kaczmarska A; Śliwa P; Zawitkowska J; Lejman M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL.
    Short NJ; Kantarjian H; Kanagal-Shamanna R; Sasaki K; Ravandi F; Cortes J; Konopleva M; Issa GC; Kornblau SM; Garcia-Manero G; Garris R; Higgins J; Pratt G; Williams LN; Valentine CC; Rivera VM; Pritchard J; Salk JJ; Radich J; Jabbour E
    Blood Cancer J; 2020 May; 10(5):61. PubMed ID: 32457305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.
    Mu Q; Guo L; Hu Y; Sheng L; Zhang Y; Wu N; Chen Y; Shi C; Shi S; Wu Y; Ouyang G
    Leuk Lymphoma; 2017 Sep; 58(9):1-3. PubMed ID: 28278724
    [No Abstract]   [Full Text] [Related]  

  • 50. T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
    Ting S; Mixue X; Lixia Z; Xueying L; Wanzhuo X; Xiujin Y
    Ann Hematol; 2020 Apr; 99(4):829-834. PubMed ID: 32107574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.
    De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Berthou C; Morel F; De Braekeleer M
    Leukemia; 2007 Oct; 21(10):2220-1. PubMed ID: 17541395
    [No Abstract]   [Full Text] [Related]  

  • 52. BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.
    Yenamandra AK; Kaviany S; Borinstein SC; Friedman DL; Kovach AE
    Lab Med; 2019 Oct; 50(4):401-405. PubMed ID: 30938769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel.
    Aoe M; Ishida H; Matsubara T; Karakawa S; Kawaguchi H; Fujiwara K; Kanamitsu K; Washio K; Okada K; Shibakura M; Shimada A
    Int J Lab Hematol; 2018 Aug; 40(4):427-436. PubMed ID: 29575541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
    Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Piccaluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G
    Blood; 2008 Nov; 112(9):3847-55. PubMed ID: 18650450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.
    Iacobucci I; Roberts KG
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34062932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A near-haploid clone harboring a BCR/ABL1 gene fusion in an adult patient with newly diagnosed B-lymphoblastic leukemia.
    Peterson JF; Ketterling RP; Huang L; Finn LE; Shi M; Hoppman NL; Greipp PT; Baughn LB
    Genes Chromosomes Cancer; 2019 Sep; 58(9):665-668. PubMed ID: 30790375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
    Roberts KG; Li Y; Payne-Turner D; Harvey RC; Yang YL; Pei D; McCastlain K; Ding L; Lu C; Song G; Ma J; Becksfort J; Rusch M; Chen SC; Easton J; Cheng J; Boggs K; Santiago-Morales N; Iacobucci I; Fulton RS; Wen J; Valentine M; Cheng C; Paugh SW; Devidas M; Chen IM; Reshmi S; Smith A; Hedlund E; Gupta P; Nagahawatte P; Wu G; Chen X; Yergeau D; Vadodaria B; Mulder H; Winick NJ; Larsen EC; Carroll WL; Heerema NA; Carroll AJ; Grayson G; Tasian SK; Moore AS; Keller F; Frei-Jones M; Whitlock JA; Raetz EA; White DL; Hughes TP; Guidry Auvil JM; Smith MA; Marcucci G; Bloomfield CD; Mrózek K; Kohlschmidt J; Stock W; Kornblau SM; Konopleva M; Paietta E; Pui CH; Jeha S; Relling MV; Evans WE; Gerhard DS; Gastier-Foster JM; Mardis E; Wilson RK; Loh ML; Downing JR; Hunger SP; Willman CL; Zhang J; Mullighan CG
    N Engl J Med; 2014 Sep; 371(11):1005-15. PubMed ID: 25207766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
    Schieck M; Lentes J; Thomay K; Hofmann W; Behrens YL; Hagedorn M; Ebersold J; Davenport CF; Fazio G; Möricke A; Buchmann S; Alten J; Cario G; Schrappe M; Bergmann AK; Stanulla M; Steinemann D; Schlegelberger B; Cazzaniga G; Göhring G
    Ann Hematol; 2020 Apr; 99(4):809-818. PubMed ID: 32078009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ABL1 fusion genes in hematological malignancies: a review.
    De Braekeleer E; Douet-Guilbert N; Rowe D; Bown N; Morel F; Berthou C; Férec C; De Braekeleer M
    Eur J Haematol; 2011 May; 86(5):361-71. PubMed ID: 21435002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
    Iacobucci I; Storlazzi CT; Cilloni D; Lonetti A; Ottaviani E; Soverini S; Astolfi A; Chiaretti S; Vitale A; Messa F; Impera L; Baldazzi C; D'Addabbo P; Papayannidis C; Lonoce A; Colarossi S; Vignetti M; Piccaluga PP; Paolini S; Russo D; Pane F; Saglio G; Baccarani M; Foà R; Martinelli G
    Blood; 2009 Sep; 114(10):2159-67. PubMed ID: 19589926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.